DFFN - Diffusion Pharmaceuticals regains compliance with Nasdaq Listing requirements
Nasdaq Listing Qualifications Staff notified Diffusion Pharmaceuticals (NASDAQ:DFFN) that it has regained compliance with the Nasdaq minimum bid price continued listing requirement. Earlier, it was notified on May 6 that it is not in compliance with the minimum bid price requirement.
For further details see:
Diffusion Pharmaceuticals regains compliance with Nasdaq Listing requirements